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Abstract
Purpose of Review Sacral neuromodulation (SNM) is being used to treat lower urinary tract symptoms (LUTS) with growing
popularity among clinicians in multiple specialties. As this therapy becomes more common in the USA and Europe, urologists
will encounter more patients implanted with SNM generators.
Recent Findings Over time, it has recently been understood that up to 53% will develop pain at the implant site as reported by
Groen et al. (J Urol 186:954, 2011) and 3–38% will lose effective stimulation as reported by Al-zahrani et al. (J Urol 185:981,
2011) and White et al. (Urology 73:731, 2009). There is a paucity of troubleshooting methodology in the literature, apart from
revision surgery, to salvage the SNM generator. In fact, it has been suggested that one contemporary series’ failure rate is lower
than some historic series because of the ability to reprogram devices as reported by Siegel et al. (J Urol 199:229, 2018). Standard
algorithms for such reprogramming efforts are lacking in the literature and may salvage some patients otherwise destined for
surgical revision or addition of multimodal therapy to achieve acceptable symptom control.
Summary It is possible to troubleshoot and thereby salvage many SNM generators, saving patients from surgical revision in
many cases and increasing the number of patients with persistent benefit from SNM. The algorithms presented in this manuscript
represent a systematic strategy for reprogramming and troubleshooting SNM generators.
Keywords Neuromodulation . Urinary incontinence . Urinary urgency . Urinary frequency . Bladder . Prosthesis and implants .
Electric stimulation . Equipment safety
Introduction
Urinary urgency, frequency, urge urinary incontinence, and
nocturia, collectively known as lower urinary tract symptoms
(LUTS) or overactive bladder (OAB), create significant mor-
bidity for patients in the USA and worldwide [1–3]. First-line
therapy includes behavior and dietary modification, while
second-line therapy includes medication. Unfortunately, while
medication can achieve roughly 70% initial success rates,
compliancewithmedication for OAB is approached 18% after
1 year of therapy [4, 5]. When medication fails to improve
symptoms of OAB, sacral neuromodulation (SNM) can be
offered as third-line therapy as currently recommended by
the American Urologic Association (AUA) guidelines on
overactive bladder [4]. A contemporary prospective registry
known as the InSite trial has demonstrated long-term safety
and efficacy for SNM in light of recent improvements to hard-
ware and technique [6••]. This carefully controlled, carefully
studied cohort of patients exhibited undesired changes in ther-
apeutic stimulation despite initial success. Twenty-two per-
cent of patients reported an undesirable change in stimulation
following successful implantation, implant site pain in 15%,
and ineffective stimulation in 13% [6••]. Many others have
reported similar changes in stimulation efficacy, some of these
appear in Table 1. As the number of SNM implants worldwide
continue to climb, addressing these unwanted changes will
become more and more important for clinicians treating
LUTS/OAB.
Many busy practices have found it necessary to trou-
bleshoot these devices following implantation, but
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standardized troubleshooting algorithms in the literature
are rare and may not address all situations [7•, 14, 15•,
16•]. In some cases, physicians rely on representatives of
the manufacturer to troubleshoot and reprogram, but in
many cases, the most appropriate person to do this is the
clinician who implanted the device, since they understand
the entire clinical picture, as well as the knowledge of
how the lead was implanted and have knowledge of
which leads provided the initial response. A step toward
standardizing the evaluation process during stage 1 SNM
lead placement was taken with the introduction of a stan-
dardized Patient Management Worksheet by the manufac-
turer, Medtronic® (Dublin, Ireland). This contains infor-
mation about which leads had the best response at the
time of implantation, and allows for the recording of lead
combinations that have already been tried so this is not
duplicated during the trial phase. A modified example can
be seen in Fig. 1. Many reviews of SNM have focused on
complications related to lead implantation or generator
placement. Some have categorized post-implantation
problems as infection-related, mechanical problems, and
response-related [7•]. Most series consider surgical revi-
sion of the lead or generator without mention of
reprogramming [17]; however, some articles dedicated to
reprogramming do exist [15•, 16•]. The following manu-
script will review the types of problems patients may
present with following successful stage 2 SNM generator
implantation, and some algorithms for programming the
SNM generator, as well as proposed causes and solutions
for these issues.
The review will be organized by patient complaint,
since that is how the problem will be presented to the
troubleshooting practitioner, with the intent of providing
a clinically useful algorithm to serve as a tool to aid trou-
bleshooters. Articles describing loss of benefit, change in
stimulation, and revision rates will be reviewed (Table 1).
It is suggested that regardless of the specific complaint, the
clinician does a few things at every encounter:
1. Check the wound for signs of infection or extruded lead or
hardware.
2. Obtain a history specifically quantifying urinary frequen-
cy, urgency, nocturia, incontinence episodes, and number
of pads used, if any. Compare this to past symptoms to
assess improvement, worsening, or stability of symptoms.
A useful adjunct is a validated questionnaire for LUTS,
per the clinician’s preference.
Patient Complaints
Perhaps the most disappointing clinic experience occurs when
a patient who previously was doing well following surgery
presents with a problem. Below are some common scenarios
patients may present with following SNM implantation.
Patient No Longer Feels the Stimulation
and No Longer Has Good Benefit
This is a frustrating and common phenomenon, especially
since the patient previously had a response good enough to
justify the generator implant. The first step is to interrogate the
device, and this is described in Algorithm 1 below. First, de-
termine that the device is turned ON and the amplitude of
stimulation is high enough that a patient can be expected to
feel it (i.e., look at the operative report and note at which
threshold the motor response was achieved). If the patient still
does not feel this level of stimulation, it is necessary to rule out
a short circuit or open circuit (crossed wires or broken wires,
Table 1 Contemporary sacral neuromodulation series (SNM)
demonstrating an undesired change in stimulation following successful
stage 1 trial. Series having abdominal generators were excluded due to the
increased rate of revision and pain complications. NA indicated not
available from the manuscript
Author Year Reprogramming
mentioned in manuscript
Number of patients Change in stimulation Lost benefit Pain from device
Hijaz [7•] 2006 Yes 161 NA 16% 2%
Siegel [6••] 2018 Yes 140 22% 13% 15%
Shih [8] 2013 No 142 NA 18% 6%
Peeters [9] 2014 No 217 NA 22% 6%
Al-Zahrani [10] 2011 No 96 13% 38% 14%
Van Voskuilen [11] 2006 No 149 43% 28% 28%
Groen [12] 2011 No 60 NA NA 53%
White [13] 2009 No 202 NA 3% 3%
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in layman’s terms). This, too, appears in Algorithm 1. If all
appears normal, it is time to change the program
(Algorithm 2), and if this is unsuccessful then it may be nec-
essary to alter the SNM signal stimulating the patient’s nerve
roots. This process is detailed in Algorithm 3. If none of these
measures can restore sensation, then it is necessary to consider
a lead migration. A KUB can be a useful study, but the exam-
iner must have obtained a baseline KUB at the time of im-
plantation, and subsequent KUBs must be done with the same
precise positioning of the patient. It has been our experience
that this is difficult to achieve in most radiology departments,
so a telephone call to the technologist can be very helpful in
establishing that one is truly comparing apples to apples and
not simply a malpositioned film. If lead migration is
suspected, then revision of the lead can be carried out.
Conservative efforts at reprogramming are advised before lead
revision is considered. There have been some cases of electri-
cal interference with the device, particularly with security sys-
tems at retail outlets, and particularly with the older 3023
model, and so if the patient reports a history of sudden change
in stimulation noted immediately after visiting an establish-
ment using wireless security systems, this should be consid-
ered. Often explant of the generator is necessary if a trial of
reprogramming fails.
Patient Feels the Stimulation in the Same
Place but No Longer Has Any Benefit
This too is frustrating for the patient, and in addition to the
measures described above, it is important to check for com-
mon transient causes of LUTS, such as UTI. Algorithm 3
should be considered early in this case, simply reprogramming
the pulse width and/or frequency can achieve stimulation in a
slightly different location and may achieve benefit. Adding
anticholinergics or beta-3 agonists to this treatment plan may
provide benefit, as may onabotulinumtoxin A, but clearly
patients would prefer a successful outcome from a single
modality.
Patient No Longer Feels the Stimulation
but Still Has Good Benefit
In this case, it is often helpful to ensure the SNMgenerator is on,
perform basic SNM generator interrogation (see algorithm 1).
As long as the generator is on and stimulation amplitude (the
“volts” is not above 5.0 V), the patient can be left alone but with
careful follow-up. If the amplitude is elevated, the patient is at
risk for early generator depletion and attempts should be made
to reduce the stimulation voltage. This can be done by changing
the active electrode (Algorithm 2) and seeking to achieve a
lower threshold of stimulation. It should be noted that it is not
necessary for a patient to feel the stimulation to have a good
therapeutic benefit.
Patient Feels the Stimulation in a Different
Place and No Longer Has Any Benefit
This is a similar situation to the lost sensation/lost benefit
scenario described above and the same algorithms (1, 2, then
3) should be followed. If it is felt in a different location but not
lost, then it is less likely that a broken wire/open circuit will be
encountered during Algorithm 1.
Pain at the Implant Site
This is a common complaint, and during the perioperative
period, after surgical site infection is ruled out, can safely be
observed in our experience and often resolves. However, if it
does not occur in the perioperative period, or does not resolve
within a month or two, it may be necessary to consider pocket
Fig. 1 Sample patient worksheet
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revision. This complaint was noted in 15% in the contempo-
rary INSITE Seigel series [6••] and up to 29.7% pooling all
types of pain in the older-generation SNM series by the same
author [18]. Outside of infection, it can be caused by stimula-
tion or by generator malposition. One way to troubleshoot this
is to turn off stimulation with the N’Vision Clinician
Programmer and have the patient return in a month. If the pain
is improved, it may be possible to eliminate the pain with
programming alone (Algorithm 3). If not, it may be beneficial
to revise the generator pocket. Our experience has been that
generators placed directly on gluteus muscle (very thin pa-
tients) or patients who have recently lost considerable weight
can benefit from pocket revision to get the device to lie paral-
lel to the plane of the skin with some distance from direct
contact with gluteus muscle.
Pain Down the Leg or Foot
Commonly, this suggests a high (2, 3) electrode is stimulating
in the S2 region as the lead traverses the nerve root, but it is
also possible the lead itself is irritating the nerve root. The first
step is to turn off the generator and have the patient return after
2–4 weeks. If turning off the stimulation improves the pain, it
may be possible to program out the harmful response by en-
ergizing (making NEGATIVE “−”) only electrodes 0 or 1, the
most distal electrodes, and routing the return current through
the case (making it POSITIVE “+”) as described in
Algorithm 2. Another option is to alter the pulse width of
the stimulation signal as described in Algorithm 3. Altering
pulse width typically changes where the patient perceives the
stimulation, and can be used to “move” the sensation from the
buttock to anus or genital area by trial and error. If turning off
the stimulation fails to improve the pain, it is likely a mechan-
ical or lead-placement issue and a lead revision might be
necessary.
Unwanted Movement of the Leg
This suggests a stimulation of S2 nerve roots and can be pro-
grammed out if any of the electrodes traverse the S3 nerve
roots. Algorithm 2 is most useful for programming unwanted
S2 stimulation out, but if this is unsuccessful, changing pulse
width and frequency as described in Algorithm 3 is worth
trying. Often, a lead revision is necessary.
Unwanted Movement of the Foot
Unlike leg movements, foot movements can often be pro-
grammed out using Algorithm 2 and Algorithm 3. A strong
S3 response can sometimes be frustrating to the patient,
especially if the motor threshold is below 1–2 V at the time
of implant. Reducing the amplitude of stimulation as well as
the frequency can help dampen the discomfort, and ramping
up the voltage slowly can also help. Foot cramping can often
result with over stimulation of the great toe. Lead revision is
an option if multiple reprogramming sessions prove
unsuccessful.
Fever and Tenderness at the Implant Site
Efforts to salvage the infected lead and generator are often
unsuccessful, but a trial of antibiotics is not unreasonable,
since the morbidity is low and reports of a serious life-
threatening infection or sepsis in the literature are extremely
rare [7•, 8].
Transient Electric Shock
Some have proposed that this is likely due to moisture in one
of the electrical connections, namely the lead connecting to
the generator [14]. It may also be due to subtle movements of
the lead and electrodes, which can shift in situ despite fixation
with the tined-lead system. Moreover, insulation could be de-
ficient, and although this is unlikely given the thick silicone
housing that covers these leads, one should be prepared to
consider any possibility when dealing with an implanted de-
vice. The first step for this complaint is to turn off the device to
determine if the output itself is the cause, or if it is due to a
mechanical cause such as the lead putting pressure directly on
a nerve root. If turning it off (see Algorithm 1) improves the
transient shock, then reprogramming to electrodes furthest
from the current settings (Algorithm 2) may help, but it is
more likely that a lead revision, without replacing the lead or
generator, will help. The goal would be to clean and dry all
connections and to tighten all bolts. Although it is highly
unlikely that a bolt has become loose or perhaps tightening
was overlooked at the time of implantation, all possibilities
should be considered. A loose bolt may not appear as an open
circuit on Algorithm 1.
Adverse Change in Bowel Function
Just as an adverse change in urinary function can often be
programmed out, it is worthwhile to first follow Algorithm 1
to make sure the SNS generator is turned on, then Algorithm 2
can be used to alter the electrode configuration. CT can be a
useful adjunct in this situation because sometimes the distal tip
of the lead can be very close to the rectum, and if this is the
case, it is worthwhile to start by altering the active electrode so
the stimulation is coming from electrode #3 (make #3
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NEGATIVE or “−”) and make the case or electrode #2
POSITIVE (“+”) to keep the stimulation away from the rectal
wall. Algorithm 3 can be used to alter the signal if sufficient
change cannot be achieved by changing the stimulating elec-
trodes. Modulating the stool consistency with fiber or osmotic
laxatives such as polyethylene glycol should also be consid-
ered, and possibly a consistent bowel program for more severe
cases.
The previous paragraphs were organized by symptom, and
many of the manuscripts organize adverse responses by pre-
sumed cause. Some common causes for the above scenarios
are discussed below.
Lead Migration
Almost every SNM series describes lead migration. After gen-
erator implantation, it is reasonable to expect that some pa-
tients will exhibit some of the changes and problems described
in the preceeding pages. One proposed cause for a change in
response is lead migration. This can be suggested by plain
KUB, but this is not always definitive. Lead migration has
been noted to occur in up to 11.8% by Hijaz and colleagues
[14] and 8.4% by Siegel and colleagues [18]. Although this
represents a mechanical problem, it can be successfully
remedied by reprogramming in some cases, and this should
be attempted as described in Algorithm 2 and 3.
Fractured Lead
Like lead migration, a fractured lead represents a mechan-
ical problem but can often be remedied by reprogramming
“around” the broken lead (s). The advantage is that
Algorithm 1, impedance testing, can locate the fractured
lead pair precisely. This should be suspected when a his-
tory of a fall is given. This is very common in children,
presumably because they are very active, and in fact
Reinberg and colleagues noted a 49% revision rate, even
after accounting for and excluding those revised for reso-
lution of symptoms [19].
Malpositioned Generator
This will often cause pain at the generator site which does
not resolve with turning the stimulation off. Moreover,
malpositioned generators are often palpable at an unusual
angle relative to the surface of the skin. If angled too
severely toward the implant scar, they may threaten to
erode through the skin. A pocket revision is often neces-
sary, and can most effectively be accomplished by incis-
ing the pseudo-capsule surrounding the generator,
removing the generator, then incising the back wall of
the pseudo-capsule and creating a new pocket parallel to
the surface of the skin but deeper than the existing pocket.
After the generator is re-implanted, both layers of pseudo-
capsule can be closed together to eliminate dead space
and reduce the chance of generator migration.
Conclusion
SNM can be a life-altering therapy for patients suffering
from LUTS or OAB but is not without drawbacks.
Effectiveness can suddenly decrease following a period
of benefit, or it can gradually decline, and clinicians
implanting SNM generators can often troubleshoot and
salvage these devices.
Algorithm 1
The Basics of SNM Generator Interrogation
1. Place the words and LED lighted section of the Clinician
Programmer face-up (so they can be seen by the clinician,
not the part facing the patient’s skin) and press the SYNC
or “P” button (Fig. 2).
2. Once the N’vision clinician programmer has communi-
cated with the SNM generator, sync the iCon Patient pro-
grammer (Fig. 2) with the clinician programmer. If it does
not connect sometimes it is necessary to cycle the iCon
patient programmer on and off using the power switch
labeled with the yellow light bulb. Enter the patient’s in-
formation if necessary.
3. Make sure the SNM generator has not been turned OFF
by looking for the icon on the screen after the N’vision
clinician programmer connects with the patient’s SNM
generator (Fig. 3).
4. Make sure the amplitude of stimulation is high enough for
the patient to feel it
5. Interrogate the leads to ensure there are no open circuits
(i.e., Broken wires, designated by > 4000 Ω signal – see
Fig. 4) and no short circuits (i.e., Water in the connection
or fused wires, designated by < 50 Ω signal – Fig. 4). It is
important to note that sometimes a lead pair will return the
> 4000Ω signal yet it is not truly broken. It is thought this
is due to increased resistivity of scar tissue that can form
around the electrode, diminishing but not eliminating its
effectiveness. If this is suspected one can increase the test
voltage used to determine open circuits. The process is
outlined in Algorithm #4.
6. Use the clinician programmer to change the program and
see if the desired stimulation can be achieved
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Algorithm 2
The Basics for Changing the Program
1. Place the words and LED lighted section of the clinician
programmer face-up (so they can be seen by the clinician,
not touching the patient’s skin) and press the SYNC but-
ton (Fig. 2).
2. Once the clinician programmer has communicated with
the SNM generator, sync the iCon Patient programmer
(Fig. 2) with the clinician programmer. If it does not con-
nect, sometimes it is necessary to cycle the iCon patient
programmer on and off using the power switch labeled
with the yellow light bulb. Enter the patient’s information
if necessary.
3. Determine which program the patient is currently using
and switch to another existing program (Fig. 3). Make
sure to increase the amplitude until the patient can feel
the stimulation. Make note of where the patient feels the
stimulation. One common program configuration in the
perioperative follow-up period is:
(a) “C1” electrode 0 NEGATIVE electrode 3
POSITIVE
(b) “C2” electrode 1 NEGATIVE electrode 3
POSITIVE
(c) “C3” electrode 2 NEGATIVE electrode 0
POSITIVE
(d) “C4” two electrodes set to NEGATIVE and the fur-
thest from both set to POSITIVE
4. If stimulation cannot be achieved by changing to an
existing program, it may be necessary to change the active
(NEGATIVE or “−”) electrode to a different location. It is
important to always give the POSITIVE electrode.
5. If altering the active electrode is still not achieving stim-
ulation in the desired location, it may be time to modify
pulse width (“msec”) or frequency (“Hz”) of the
Fig. 3 Initial screen demonstrating programs available to the clinician.
The top menu is useful for accessing the programs, reprogramming,
interrogating lead integrity, syncing the changed programs to the iCon
patient programmer, and exiting the programming session. Below the
amplitude (“voltage”) indicator, the icon for modifying the stimulation
signal itself can be seen
Fig. 2 Icon patient programmer and Medtronic Clinician Programmer,
with the antenna extended for both. Arrow points to the “SYNC” button
of each device. It is necessary to push the “SYNC” button on the clinician
programmer to program a SNM device
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stimulation signal. This maneuver can alter where the pa-
tient feels the stimulation by recruiting different nerve
bundles or nerve roots.
Algorithm 3
Modifying Pulse Width and Frequency to Alter Where
the Patient Feels the Stimulation
1. Perform basic interrogation and basic routine for chang-
ing the program. Some have noted that the motor response
is more predictive for a good long-term successful implant
than the sensory response [20], but increasing the stimu-
lation amplitude to levels sufficient to elicit a motor re-
sponse outside of the operating room setting is often quite
uncomfortable for the awake patient in-office, so sensory
response is used in clinic. Sensation that is most desirable
is in the genital area, but opinions on this differ. Many try
to avoid sensory stimulation affecting the thigh or toes,
although a motor toe response is a desirable response
during implantation, suggesting stimulation of the S3
Fig. 4 Lead interrogation screen demonstrating broken wires (“>
4000 Ω”) and short circuits, possibly from moisture (“< 50 Ω”)
Fig. 5 Stimulation signal modification screen. The area to the right of
“PW” demonstrates the pulse width modification icon which is normally
set to 220 μs but can achieve stimulation from 60 to 400 μs. The area to
the right of “Rate” demonstrates the frequency modification icon,
normally set from 9.7 to 12 Hz, but which can be adjusted from 9.0 up
to 60 Hz. The higher frequency stimulation is associated with more
intense and sometimes uncomfortable stimulation, allowing the
clinician to decrease the stimulation amplitude and sometimes recruiting
different nerve root bundles allowing the clinician to salvage leads that
otherwise may not be stimulating in the appropriate areas. “Amplitude
Limit” sets a limit on how high the patient can turn up the stimulation,
normally set to the maximum 10 V. “Soft Start/Stop” allows a gentle
ramping up of stimulation so that when stimulation is initiated, it is not
as startling to the patient. “Cycling” allows the SNS generator to turn
itself “ON” and “OFF” every 8 s (set by the clinician), for a period of
time set by the clinician
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nerve roots. Movement of the great toe following implan-
tation at low stimulation levels can be distracting and
sometimes painful for patients.
2. Modify the active electrode as described in Algorithm 2.
If unsuccessful, go to the icon for altering signal parame-
ters (see Fig. 5).
3. Identify the icon for pulse width modification (Fig. 5).
The label “PW” demonstrates the pulse width modifica-
tion icon which is normally set to 220 μs but can achieve
stimulation from 60 μs to 450 μs. Make note of where the
stimulation is set.
4. Start with a lower pulse width by 100 μs than the
current setting, ask the patient if they feel this at all,
then ask if the location has changed, even a little,
from the pre-modification stimulation. Then increase
pulse width to 100 μs higher than the starting pulse
width noted upon starting the process. If the stimula-
tion moves to a genital location close out of the menu,
SYNC the device (“P” button) to send the new pro-
gram to the SNM generator. If modification of the
pulse width is not adequate to achieve desired sensory
response, move on to modification of frequency of
stimulation.
5. Identify the icon for frequency modification (Fig. 5).
The label “Rate” demonstrates the frequency modifi-
cation icon, normally set from 9.7 to 14 Hz, but which
can be adjusted from 2.1 up to 130 Hz. Make note of
the frequency to which the current stimulation is set.
The higher frequency stimulation is associated with
more intense and sometimes uncomfortable stimula-
tion, allowing the clinician to decrease the stimulation
amplitude and sometimes recruiting different nerve
root bundles allowing the patient wider therapeutic
options.
6. Increase the frequency of stimulation by 10 Hz. Warn
the patient, this may be uncomfortable. Ask if they
can now feel the stimulation in a different location.
Any change that is not painful or uncomfortable is a
reasonable stopping point.
7. SYNC the device (“P” button) to send the new program to
the SNM generator.
8. After all programming is completed, move to the 4th
item on the menu bar (Fig. 3) and SYNC the iCon
patient programmer with the clinician programmer. If
this step is not completed, or if the patient did not
come with the iCon patient programmer, the new pro-
gram will remain on the SNM generator only as long
as the patient’s iCon patient programmer is not used
to interrogate, increase the amplitude, or in general
“talk” to the SNM generator. As soon as the not-
updated iCon patient programmer SYNCs with the
SNM generator, it will revert all programs to what it
thinks they should be.
Algorithm 4
Modifying Test Voltage for Lead Impedance Testing
Figure 4 demonstrates the impedance testing screen, immedi-
ately below electrode impedance label appears the “Amp (V)”
label. This is set to 1.0 V by default and can be increased to
increments of 0.1 V. If by 2.0 V the impedance still reads “>
4000 Ω,” then it is likely that the lead is broken.
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